Key PointsQuestion
Are nonspecialist providers (such as lay counselors, nurses, midwives, and teachers with no formal training in counseling interventions) effective at preventing and treating perinatal depression and anxiety, and what are the relevant implementation processes for nonspecialist-delivered interventions?
Findings
This systematic review of 46 trials (18 321 participants) and meta-analysis of 44 trials (18 101 participants) found that, compared with control groups, nonspecialist-delivered interventions were associated with lower depressive and anxiety symptoms for both preventive and treatment interventions, but there was high heterogeneity among the included trials. The majority of interventions were implemented in Australia, UK, and US, conducted by nurses and midwives, and delivered in person, in person combined with the telephone, or via telephone only, with only 2 interventions delivered online.
Meaning
This study found evidence in high-income countries to support that nonspecialist providers may be effective in preventing and treating perinatal depressive and anxiety symptoms, which suggests that integrating nonspecialist providers to deliver evidence-based counseling interventions has the potential to address the significant burden of perinatal depression and anxiety worldwide.
Importance
Task sharing—or training of nonspecialist providers with no formal training in counseling—is an effective strategy to improve access to evidence-based counseling interventions and has the potential to address the burden of perinatal depression and anxiety.
Objectives
To identify the relevant implementation processes (who, what, where, and how) and to assess the effectiveness of counseling interventions delivered by nonspecialist providers for perinatal depression and anxiety in high-income countries.
Data Sources
CINAHL, Ovid MEDLINE, Ovid MEDLINE In-Process, PsycINFO, Web of Science, Cochrane Central Register of Controlled Trials, and Embase through December 31, 2019. Relevant systematic reviews were also considered.
Study Selection
Randomized clinical trials of counseling interventions that assessed depression or anxiety after intervention, delivered by a nonspecialist provider for adults, and that targeted perinatal populations in a high-income country were included. Self-help interventions that did not include a provider component were excluded.
Data Extraction and Synthesis
Four researchers independently reviewed abstracts and full-text articles, and 2 independently rated the quality of included studies. Random-effects meta-analysis was used to estimate the benefits of the interventions. The Preferred Reporting Items for Systematic Reviews and Meta-analyses reporting guideline was followed.
Main Outcomes and Measures
For implementation processes, the frequencies represented by a total or percentage were estimated, where the denominator is the total number of eligible trials, unless otherwise indicated. For effectiveness, primary and secondary outcome data of depression, anxiety, or both symptoms were used, with separate analyses for prevention and treatment, stratified by depression or anxiety. Subgroup analyses compared outcome types (anxiety vs depression) and study objectives (treatment vs prevention).
Results
In total, 46 trials (18 321 participants) were included in the systematic review; 44 trials (18 101 participants) were included in the meta-analysis. Interventions were implemented across 11 countries, with the majority in Australia, UK, and US. Two-thirds (65%) of counseling interventions were provided by nurses and midwives, lasted a mean of 11.2 weeks (95% CI, 6.4-16.0 weeks), and most were delivered face to face (31 [67.4%]). Only 2 interventions were delivered online. A dearth of information related to important implementation processes, such as supervision, fidelity, and participant sociodemographic characteristics, was observed in many articles. Compared with controls, counseling interventions were associated with lower depressive symptoms (standardized mean difference [SMD], 0.24 [95% CI, 0.14-0.34]; 43 trials; I2 = 81%) and anxiety scores (SMD, 0.30 [95% CI, 0.11-0.50]; 11 trials; I2 = 80%). Treatment interventions were reported to be effective for both depressive symptoms (SMD, 0.38 [95% CI, 0.17-0.59]; 15 trials; I2 = 69%) and anxiety symptoms (SMD, 0.34 [95% CI, 0.09-0.58]; 6 trials; I2 = 71%). However, heterogeneity was high among the trials included in this analysis.
Conclusions and Relevance
This study found evidence in high-income countries indicating that nonspecialist providers may be effective in delivering counseling interventions. Additional studies are needed to assess digital interventions and ensure the reporting of implementation processes to inform the optimal delivery and scale-up of these services.
An estimated 10% to 15% of women experience depression during pregnancy or in the year following childbirth.1,2 In addition, approximately 15% to 20% of women experience anxiety symptoms perinatally.3 Many of those symptoms begin during the antenatal period,4 with annual costs amounting to more than $45.9 billion.5
Counseling interventions, notably cognitive, behavioral, and interpersonal therapies, are widely effective in preventing and treating major depression and anxiety disorders in perinatal women.6,7 Although the US Preventive Services Task Force has endorsed counseling interventions for women at risk of perinatal mood disorders,8 fewer than 20% of women with perinatal depression have access to these interventions.9 The poor dissemination and uptake of effective counseling interventions is due, in part, to the limited number of skilled mental health professionals.
Task sharing is the “rational redistribution of tasks”10 and has been used worldwide to improve access to health care. Nonspecialist providers (NSPs)—individuals with no formal training in mental health, such as lay counselors, nurses, midwives, and teachers—have been trained to prevent and treat perinatal depressive and anxiety symptoms worldwide.11,12 In low- and middle-income countries, task sharing has wide currency,13 with NSPs considered an important human resource because they are widely available, are cost-effective, and have regular, frequent contact with mothers.14,15
In high-income countries (HICs), the concept of NSPs for mental health care delivery has its own unique history, dating back to the paraprofessional movement in the United States and in the United Kingdom. More recently, NSPs have been successfully trained to address perinatal mental health in HIC contexts.16,17 Thus, NSPs may have the potential to address the startling treatment gap for depression18 and anxiety.19
In low- and middle-income countries, previous syntheses of NSP-delivered psychological interventions for perinatal populations11,20 have been conducted. Examining these processes and their effectiveness may be helpful to improve the implementation and scale-up of counseling interventions to potentially address the significant burden of perinatal depression and anxiety across HICs.
Our primary objective was to conduct a systematic review and meta-analysis to answer the following 2 questions: (1) What are the relevant implementation processes associated with the who (type of NSP), how (training and supervision), what (type of treatment), and where (type of setting) of NSP-delivered counseling interventions for perinatal depressive or anxiety symptoms in HICs? (2) Are NSP-delivered counseling interventions associated with effective prevention or treatment of depressive or anxiety symptoms among perinatal women residing in HICs?
This study used the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) reporting guideline21 (eTable 1 in the Supplement) and followed the procedures of a recent review by members of our team of NSP-delivered interventions.11 This study is registered with PROSPERO.22
A member of our team (B.A.K.) conducted the electronic search for articles, with no time or language restrictions. Literature sources included CINAHL, Ovid MEDLINE, Ovid MEDLINE In-Process, PsycINFO, Web of Science, Cochrane Central Register of Controlled Trials, and Embase through December 31, 2019. Bibliographies of 108 systematic reviews of psychological interventions for perinatal populations in HICs were also considered.23-25 Information was collected from primary trial articles and secondary articles (trial protocols, treatment development articles, or secondary analyses).
The inclusion criteria were as follows:
An HIC setting, defined by the World Bank Group in 2015 at the time of the trial,26 and exceptions made for Hong Kong and Taiwan;
The counseling intervention involved a 2-way interaction between an NSP therapist and a client that focused on changing one’s patterns and improving skills27;
A diagnosis or assessment using a validated tool in which symptoms of depression or anxiety were the primary or secondary outcome (after intervention);
Included pregnant or postpartum (up to 1 year after delivery) adult women; and
Evaluated through a randomized clinical trial (RCT).
The 2 exclusion criteria were self-help treatments without an NSP delivery component and published materials from books, conference papers, and theses.
Trial Selection and Data Extraction
Members of our team (J.W.J., Z.M., C.R., and N.Z.) systematically screened titles and abstracts to identify potentially eligible studies, of which full texts were then retrieved for further examination. A standardized data extraction form was used by those 4 team members to extract information regarding implementation processes (Box). Articles deemed ineligible or disagreements regarding eligibility were verified by another team member and, if needed, by the study leaders (D.R.S. and A.L.). The κ scores were calculated to estimate interrater reliability between researchers, resulting in a good score of κ = 0.75.
Box Section Ref IDBox.
Checklist of Extracted Key Implementation Processes
Where?
Country
Geographical scope
Intervention setting
Who?
Delivery agent
Specialist
Participants
Target population
Age
Marital status
No. of children
Sociodemographic variables (educational, race/ethnicity, and income levels)
Were other family members involved in the intervention?
What?
Treatment theory
Treatment rationale
How?
For the meta-analysis, we extracted mean (SD) values of the primary end points for both the intervention and the control groups and their respective sample sizes. When mean (SD) values were not available, we extracted the binary outcome data, with which we were able to estimate the effect size using an online calculator.28 For studies reporting median values and ranges, we estimated the effect size via a second online calculator.29 Effective sample sizes were used for all cluster trials, using reported or estimated intraclass correlation coefficients. When multiple control groups were available, data from active control groups were prioritized for extraction.
Assessment of Risk of Bias
The Cochrane Collaboration tool for assessing risk of bias30 was used by a minimum of 2 independent coauthors (Z.M., C.R., or N.Z.) to review the included studies (κ = 0.79). This included random sequence generation, allocation concealment, selective reporting, masking of research personnel and participants, masking of outcome assessors, attrition bias, and other biases. Studies meeting 3 or more high-risk criteria or missing details were considered low quality according to previously established criteria31 (eFigure 1 in the Supplement).
We estimated the frequencies of all implementation processes, represented by a total or percentage, where the denominator was the total number of eligible trials, unless otherwise indicated (eg, when data were not specified or were missing for a particular variable). When possible, the mean was calculated along with the 95% CI. When ranges were provided for a particular variable (eg, 6-10 sessions), the mean was used (eg, 8 sessions). Outliers were identified, and analyses were repeated without these outliers.
For the meta-analyses, we used all available primary and secondary outcome data for perinatal depression, anxiety, or both for each trial. Analyses were performed using Review Manager, version 5.3,32 with the results presented as forest plots of standardized mean differences (SMDs), their 95% CIs, and relative weights calculated as the inverse of the variance and accounted for both original within-study variance and between-study variance τ.33 The SMDs were estimated using Hedges g,34 with between-group postintervention mean values.35 We used a random-effects analysis36 because of the expected heterogeneity. A test for subgroup differences was conducted comparing prevention and treatment trials, evidence-based (eg, interpersonal psychotherapy [IPT] and cognitive-behavioral therapy [CBT]) vs non–evidence-based interventions (supportive counseling); sample age demographic characteristics (adult only vs mixed adolescents and adults); and outcome measure (clinical diagnostic tool vs self-report). We conducted a post hoc sensitivity analysis using leave-1-out analyses to test the effect of excluding single trials that had the largest and smallest sample size and the largest and smallest effect sizes. This was conducted separately for treatment and prevention trials and for outcomes of interest (depression and anxiety).
Figure 1 shows the flowchart of eligible articles. In total, 46 trials (18 321 participants) were included in the systematic review, and 44 trials (18 101 participants) were included in the meta-analysis. Two trials were excluded from the meta-analysis because the active control group included specialists37 and because of insufficiently reported outcomes.38
Of the eligible trials (eTable 2 in the Supplement), 42 were individual RCTs, and 4 were cluster RCTs. The trials were conducted in 11 countries, including Australia (12 trials [26.1%]), the United Kingdom (10 trials [21.7%]), the United States (10 trials [21.7%]), Canada (3 trials [6.5%]), Scotland (3 trials [6.5%]), Sweden (2 trials [4.3%]), and Singapore (2 trials [4.3%]) and 1 trial (2.2%) each in Hong Kong, Finland, Norway, and Taiwan. Participants were recruited primarily from primary care settings (44 trials [95.7%]) followed by online methods (2 trials [4.3%]). The median trial sample size was 186 participants (range, 37-2064 participants). Participants were primarily from an urban population (31 trials [67.4%]) followed by semiurban (7 trials [15.2%]) and rural (2 trials [4.3%]) populations. Most participants were selected based on a self-report measure of depression (35 trials [76.1%]) rather than a diagnostic interview (11 trials [23.9%]). Most studies focused on the prevention of maternal mental health symptoms (28 trials [60.9%]), treatment (17 trials [37.0%]), or both (1 trial [2.2%]).
Delivery Agents, Specialists, and Participants
The most common type of NSP were midwives (16 trials) followed by nurses (14 trials), peers or community members (10 trials), health visitors (4 trials) or junior research staff (4 trials), occupational therapists (3 trials), family physicians (2 trials), and community health workers (1 trial), with at least 5 trials using a combination of NSP cadre previously mentioned. The NSPs were selected owing to their involvement with perinatal populations in an existing health care service (11 trials [23.9%]); however, most studies (35 [76.1%]) did not provide a rationale for NSP selection.
The primary roles of mental health specialists included acting as a supervisor (16 trials [34.8%]), a trainer in the selected treatment (14 trials [30.4%]), or a research evaluator (12 trials [26.1%]) or providing referrals (4 trials [8.7%]).
The target population typically included general primary care attendees (31 trials [67.4%]), most of whom were recruited from obstetrical units (n = 21) if specified, primary care attendees who were at high risk (15 trials [32.6%]), or general perinatal populations outside of the hospital (2 trials [4.3%]). Primary care settings included obstetrical, family medicine, or mental health clinics or a ward within a hospital (31 trials [67.4%]), a collection of clinics within a certain area (8 trials [17.4%]), other community health programs (3 trials [6.5%]), general practitioners (2 trials [4.3%]), or an unspecified health-related program (1 trial [2.2%]). Those considered at high risk were identified based on a self-reported risk scale (7 of 15 trials [46.7%]) or by being part of a low-income group (5 trials [33.3%]) or an ethnic minority (3 trials [20%]), having a traumatic birth experience (2 trials [13.3%]), or having a history of mental illness (1 trial [6.7%]).
All studies included adult women between 18 and 45 years of age; however, 9 trials also included adolescent participants,39-47 some as young as 14 years. Marital status was reported in 34 trials, in which most participants were married (19 trials [55.9%]) but a sizable number were divorced or separated (14 trials [41.2%]). The mean (SD) number of children in reported studies (24 trials) was 1.88 (0.86) children per participant. Most studies did not report important socioeconomic variables, such as educational level (24 trials [52.2%]) or race/ethnicity (19 trials [41.3%]). Among studies that did, most participants had completed some form of secondary education (16 of 25 trials [64.0%]); the majority of the sample was categorized as White (12 of 20 trials [60.0%]) followed by Latinx (4 trials [20.0%]), Black (2 trials [10.0%]), and Asian (2 trials [10.0%]). Of 46 trials, 10 (21.7%) reported involving either the participant’s spouse or partner (5 [50.0%]) or her child (5 [50.0%]).
Most interventions were described as supportive counseling (18 of 46 trials [39.1%]) or as an evidence-based psychological treatment (17 trials [37.0%]), such as CBT (n = 12), IPT (n = 3), or behavioral activation (n = 2) or as some combination of psychoeducation related to maternal mental health and parenting and self-efficacy (10 trials [21.7%]) or stress debriefing (2 trials [4.3%]). The rationale for selecting a particular treatment modality was identified in 26 trials (56.5%) and included being a contextually relevant treatment (7 of 26 trials [26.9%]), maintaining maternal or child health during or after pregnancy (6 trials [23.1%]), providing support (5 trials [19.2%]), using an evidence-based treatment (4 trials [15.4%]), being cost-effective (2 trials [7.7%]), reaching at-risk groups (n = 2), and deploying existing resources (n = 2).
The intervention setting was reported in 38 trials. More than half the trials were conducted within nonmental health primary care settings (20 of 38 trials [52.6%]), including child health or obstetric clinics, general practice, and other locations within the hospital, at home or by telephone (16 trials [42.1%]), online (1 trial [2.6%]), or within (1 trial [2.6%]) the community. In the minority of trials that mentioned why the particular setting was selected (n = 6), patient centeredness and flexibility were listed (4 [66.7%]), followed by feasibility (2 [33.3%]). For those trials that reported barriers in current care (n = 5), they reported an intervention delivered via telephone when it was intended for in-person treatment (1 [20%]), language barriers (1 [20%]), attitudinal barriers such as stigma (1 [20%]), or preference for in-person sessions (2 [40%]). Facilitators (n = 2) included the provision of food for the study participant and peer connection.
Intervention Delivery and Monitoring
Treatment Characteristics
Most treatments were delivered face to face (31 trials [67.4%]), through a combination of face to face and telephone (10 trials [21.7%]), or via telephone only (3 trials [6.5%]). Only 1 study (2.2%) delivered treatment via the internet,48 and 1 other study (2.2%) delivered treatment via a combination of the internet (email and communication applications) and the telephone.49 Almost all studies (42 trials [91.3%]) reported whether a group or individual format was used, with most delivering treatment individually (30 of 42 trials [71.4%]) or in group formats (12 trials [28.6%]). Treatments lasted a mean of 11.2 weeks (95% CI, 6.4-16.0 weeks), with a mean of 5.9 (95% CI, 4.9-7.0) intended sessions compared with a mean of 4.8 (95% CI, 3.8-5.8) actual sessions completed; however, this information was only reported by half of the eligible trials (n = 23). In 6 of 23 studies (26.1%) reporting treatment dosage, the number of sessions was variable, determined by the NSP and not specified.
Training methods were only reported for half of the trials (23 [50%]). Most trials reportedly used didactic practices (12 of 23 [52.2%]) or a mix of didactics and practice approaches (9 [39.1%]). The duration of training was reported in 15 of 46 trials (32.6%). Training typically lasted between 0.5 and 5 days (10 trials [66.7%]), but 3 trials (20%) indicated that training lasted between 1 week and 1 month,38,43,50 1 trial (6.7%)51 reported 3 months’ training, and 1 trial (6.7%)52 conducted training that lasted a year, in which the NSPs received training during a year-long counseling course. Only 8 trials reported an assessment of treatment quality through fidelity ratings, and only 2 trials mentioned a requirement of a competency evaluation.
Supervision methods were reported by only 6 of 46 trials (13.0%). Most of those methods involved observing sessions (3 trials [50%]), listening to audio-recorded sessions (1 trial [16.7%]), or both (1 trial [16.7%]) or providing consultation on an ad hoc basis (1 trial [16.7%]). Only 4 studies reported using a supervision format, including group supervision (1 of 4 [25%]), individual supervision (2 [50%]), or a combination of both (1 [25%]). Supervision frequency was reported in 8 trials and was conducted weekly (5 trials [62.5%]) or biweekly (1 trial [12.5%]) or the frequency varied (2 trials [25.0%]). Supervision was typically provided by a mental health expert, such as a psychiatrist or psychologist. No trials used peer supervision models.
Control groups were described by 44 of 46 (95.6%) trials. Most trials reported using treatment as usual or routine care without specifying what either involved (25 of 44 [56.8%]), treatment as usual with routine home or clinic visits (10 [22.7%]), treatment as usual with provision of community resources and referrals (4 [9.1%]), and treatment as usual with provision of postpartum education (2 [4.5%]). Of 44 trials, 3 (6.8%) reported delivering support to the control group, including peer support (1 [2.3%]),43 a single debriefing session (1 [2.3%]),53 and interpersonal therapy by specialists (1 [2.3%]).37
Effectiveness of NSP-Delivered Interventions
We included 44 trials in the meta-analysis. The most common outcome assessment tool used for the primary outcome of depression was the Edinburgh Postnatal Depression Scale,54 which was used in 30 of 44 trials (68.2%); 7 trials (15.9%) included a diagnostic interview. In 11 trials, anxiety was assessed using a self-report measure, such as the State-Trait Anxiety Inventory55 (4 trials [36.4%]), the Generalized Anxiety Disorder 7-item scale56 (2 trials [18.2%]), or the Depression Anxiety Stress Scales57 (3 trials [27.3%]). Compared with controls, counseling interventions were associated with lower depressive symptoms (SMD, 0.24 [95% CI, 0.14-0.34]; 43 trials; I2 = 81%) and anxiety scores (SMD, 0.30 [95% CI, 0.11-0.50]; 11 trials; I2 = 80%). However, heterogeneity was high among the trials included in this analysis.
Figure 2 presents the forest plot of the effectiveness analyses for 15 trials17,32,39,40,42-49,52,53,58-86 that focused on treatment of depression as the primary or secondary outcome. In those trials, the SMD was 0.38 (95% CI, 0.17-0.59; I2 = 69%). Figure 2 also presents the forest plot of the effectiveness analysis for 28 trials focused on prevention that reported depression as a primary or secondary outcome. For those trials, the SMD was 0.19 (95% CI, 0.08-0.30), favoring the intervention, with the inconsistency measure (I2 = 81%) suggesting substantial heterogeneity among the trials.
Figure 317,48,49,52,62,63,67,77,85-87 presents the effectiveness analyses for 6 trials focusing on treatment of anxiety as the primary or secondary outcome. For those trials, the SMD was 0.34 (95% CI, 0.09-0.58; I2 = 71%). Figure 3 also presents the effectiveness analyses for 5 trials focusing on prevention that reported anxiety as a primary or secondary outcome. For those trials, the SMD was 0.31 (95% CI, −0.03 to 0.64; I2 = 88%). The effective sample sizes and mean (SD) values for all studies are given in eTable 3 in the Supplement. Leave-1-out analyses are presented in the eAppendix in the Supplement.
The Table provides the SMD, 95% CIs, and high heterogeneity estimates (I2) for all trials and for subgroup analyses, by condition, treatment vs prevention, evidence-based treatment, sample age, and outcome measure. There were no statistically significant differences when comparing diagnostic vs self-reported outcomes (eFigure 2 in the Supplement); however, there were stronger effect sizes for evidence-based treatments (eg, CBT, IPT, and BA) compared with non–evidence-based treatments (eg, supportive counseling). Trials including mixed age samples (both adolescents and adults) showed no treatment benefit for depression, whereas samples of only adults showed significant benefit of treatment for depression (eFigure 3 in the Supplement).
A systematic assessment of risk bias was conducted (eTable 2 and eFigure 1 in the Supplement). We found low risk of bias on randomization and outcome blinding. Although the most commonly used random allocation method was opaque envelopes containing computer-generated random numbers, details related to allocation concealment and masking of participants and personnel were frequently lacking.
The present study examined the implementation processes and effectiveness of counseling interventions delivered by NSPs for perinatal depression and for anxiety in HICs. Our results highlight findings relevant to the delivery and scalability of effective NSP-delivered interventions.
First, the present study found an impressive and growing evidence base of 46 RCTs examining NSP-delivered interventions for perinatal populations, highlighting the importance of task sharing in HIC contexts. Since having conducted our search, there has been at least 1 RCT showing the effectiveness of NSP-delivered counseling interventions in perinatal populations.88 We highlight that NSPs can be trained to fulfill an important gap in the provision of effective psychological interventions for both depression and anxiety treatments. Consistent with the wider literature,89 effect sizes were stronger for treatments compared with preventive interventions.
Second, most studies included herein trained nurses and midwives to deliver counseling interventions. These findings are consistent with a recent qualitative study that independently found that nurses and midwives were considered to be the most preferred nonspecialist provider to deliver counseling interventions for perinatal interventions.90 This reflects the contextual reality of HICs, with nurses and midwives being frontline workers who can provide adequate and effective mental health care to perinatal populations.
Third, we found stronger effect sizes for evidence-based treatments (eg, CBT, IPT, and behavioral activation) compared with non–evidence-based treatments (eg, supportive counseling). This is similar to other analyses that have suggested CBT and IPT are superior to other interventions in both treatment6 and prevention91 of perinatal depression and anxiety. Considering our findings that NSPs can effectively deliver manualized evidence-based psychotherapies, such as CBT and IPT,17,37,38,40,45,48,58-66 these approaches should be advocated for NSPs, just as they are for specialists. Although “supportive” interventions may be simpler for training, further research is needed to expand the evidence base for these approaches.
Fourth, similar to effective NSP-delivered interventions for perinatal populations in low- and middle-income countries,11 we found that most studies relied on conventional face-to-face methods for intervention delivery, training, and supervision. No trial used peer supervision methods despite their potential to address the bottleneck imposed by relying on expert supervisors.92 Digital platforms for intervention delivery, the provision of training and supervision, and the demonstration of the reliability and validity of peer supervision all offer potential solutions to facilitate scaling up of quality-ensured interventions. This is particularly relevant during the ongoing coronavirus pandemic in which one of the most important lessons is how much of our daily roles and activities can be moved to digital platforms. To address the burden of perinatal depression and anxiety, it will be essential to offer and assess evidence-based counseling interventions through digital platforms and for RCTs to compare their relative effectiveness with traditional in-person models of delivery and supervision.
In addition to the high rates of heterogeneity observed among the included trials, a major limitation of this study is the dearth of relevant indicators related to important implementation processes reported by authors. For example, only half of eligible trials reported treatment dosages and less than 15% of eligible trials reported key processes related to supervision. We recommend that authors of trials systematically report key implementation details (Box), as has been proposed for other public health, behavior change interventions.93 Our review was limited to samples composed of adults, which included some studies with mixed adult and adolescent populations. We found no observed benefit for studies that included both adolescents and adults compared with adult-only studies. This highlights the need for future reviews of NSP-delivered interventions for adolescents, a highly vulnerable group for perinatal depression and anxiety.
In sum, this study synthesizes a compelling evidence base that suggests that NSPs effectively deliver preventive and treatment interventions to manage perinatal depression and anxiety symptoms in HICs. The potential for such approaches is now widely accepted for mental health care globally94 and increasingly being advocated for in high-resource contexts.13 This delivery strategy may address one of the most significant gaps in mental health care (ie, access to evidence-based counseling interventions) to influence perinatal populations worldwide.
Accepted for Publication: December 7, 2020.
Published Online: February 3, 2021. doi:10.1001/jamapsychiatry.2020.4556
Corresponding Author: Daisy R. Singla, PhD, Department of Psychiatry, Sinai Health, University of Toronto, 600 University Ave, Room 914A, Toronto, ON M5G 1X5, Canada (daisy.singla@utoronto.ca).
Author Contributions: Messrs Jung and Meng and Mss Ratjen and Zahedi contributed equally to this work. Drs Singla and Lawson had full access to all the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.
Concept and design: Singla, Patel.
Acquisition, analysis, or interpretation of data: Singla, Lawson, Kohrt, Jung, Meng, Ratjen, Zahedi, Dennis.
Drafting of the manuscript: Singla, Lawson, Jung, Meng, Ratjen, Zahedi.
Critical revision of the manuscript for important intellectual content: Lawson, Kohrt, Zahedi, Dennis, Patel.
Statistical analysis: Singla, Lawson, Kohrt, Jung, Meng, Zahedi.
Obtained funding: Singla.
Administrative, technical, or material support: Singla, Lawson, Meng, Ratjen.
Supervision: Singla, Dennis, Patel.
Conflict of Interest Disclosures: None reported.
Funding/Support: Dr Singla is supported in part by an Academic Scholars Award from the Department of Psychiatry at the University of Toronto and by the Pragmatic Clinical Studies award PCS-2018C1-10621 from the Patient Centered Outcomes Research Institute.
Role of the Funder/Sponsor: The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
8.Curry
SJ, Krist
AH, Owens
DK,
et al; US Preventive Services Task Force. Interventions to prevent perinatal depression: US Preventive Services Task Force Recommendation Statement.
JAMA. 2019;321(6):580-587. doi:
10.1001/jama.2019.0007
PubMedGoogle ScholarCrossref 10.World Health Organization, PEPFAR & UNAIDS. Task Shifting: Rational Redistribution of Tasks Among Health Workforce Teams: Global Recommendations and Guidelines. World Health Organization; 2007.
12.Hoeft
TJ, Fortney
JC, Patel
V, Unützer
J. Task-sharing approaches to improve mental health care in rural and other low-resource settings: a systematic review.
J Rural Health. 2018;34(1):48-62. doi:
10.1111/jrh.12229
PubMedGoogle ScholarCrossref 15.O'Mahen
HA, Grieve
H, Jones
J, McGinley
J, Woodford
J, Wilkinson
EL. Women's experiences of factors affecting treatment engagement and adherence in internet delivered behavioural activation for postnatal depression.
Internet Interventions. 2015;2(1):84-90. doi:
10.1016/j.invent.2014.11.003Google ScholarCrossref 19.Alonso
J, Liu
Z, Evans-Lacko
S,
et al; WHO World Mental Health Survey Collaborators. Treatment gap for anxiety disorders is global: results of the World Mental Health Surveys in 21 countries.
Depress Anxiety. 2018;35(3):195-208. doi:
10.1002/da.22711
PubMedGoogle ScholarCrossref 20.Rahman
A, Fisher
J, Bower
P,
et al. Interventions for common perinatal mental disorders in women in low- and middle-income countries: a systematic review and meta-analysis.
Bull World Health Organ. 2013;91(8):593-601I. doi:
10.2471/BLT.12.109819
PubMedGoogle ScholarCrossref 25.O’Connor
E, Senger
CA, Henninger
ML, Coppola
E, Gaynes
BN. Interventions to prevent perinatal depression: evidence report and systematic review for the US Preventive Services Task Force.
JAMA. 2019;321(6):588-601. doi:
10.1001/jama.2018.20865
PubMedGoogle ScholarCrossref 27.Cuijpers
P, Karyotaki
E, Reijnders
M, Purgato
M, Barbui
C. Psychotherapies for depression in low- and middle-income countries: a meta-analysis.
World Psychiatry. 2018;17(1):90-101. doi:
10.1002/wps.20493
PubMedGoogle ScholarCrossref 30.Higgins
JP, Altman
DG, Gøtzsche
PC,
et al; Cochrane Bias Methods Group; Cochrane Statistical Methods Group. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials.
BMJ. 2011;343:d5928. doi:
10.1136/bmj.d5928
PubMedGoogle ScholarCrossref 34.Hedges
LV. Distribution theory for Glass's estimator of effect size and related estimators.
J Educ Statistics. 1981;6(2):107-128. doi:
10.2307/1164588 41.Cooper
PJ, De Pascalis
L, Woolgar
M, Romaniuk
H, Murray
L. Attempting to prevent postnatal depression by targeting the mother-infant relationship: a randomised controlled trial.
Prim Health Care Res Dev. 2015;16(4):383-397. doi:
10.1017/S1463423614000401
PubMedGoogle ScholarCrossref 43.Letourneau
N, Stewart
M, Dennis
CL, Hegadoren
K, Duffett-Leger
L, Watson
B. Effect of home-based peer support on maternal-infant interactions among women with postpartum depression: a randomized, controlled trial.
Int J Ment Health Nurs. 2011;20(5):345-357. doi:
10.1111/j.1447-0349.2010.00736.x
PubMedGoogle ScholarCrossref 44.Lieu
TA, Braveman
PA, Escobar
GJ, Fischer
AF, Jensvold
NG, Capra
AM. A randomized comparison of home and clinic follow-up visits after early postpartum hospital discharge.
Pediatrics. 2000;105(5):1058-1065. doi:
10.1542/peds.105.5.1058
PubMedGoogle ScholarCrossref 45.Segre
LS, Brock
RL, O’Hara
MW. Depression treatment for impoverished mothers by point-of-care providers: a randomized controlled trial.
J Consult Clin Psychol. 2015;83(2):314-324. doi:
10.1037/a0038495
PubMedGoogle ScholarCrossref 46.Taft
AJ, Small
R, Hegarty
KL, Watson
LF, Gold
L, Lumley
JA. Mothers’ AdvocateS In the Community (MOSAIC)—non-professional mentor support to reduce intimate partner violence and depression in mothers: a cluster randomised trial in primary care.
BMC Public Health. 2011;11(1):178. doi:
10.1186/1471-2458-11-178
PubMedGoogle ScholarCrossref 47.Toohill
J, Fenwick
J, Gamble
J,
et al. A randomized controlled trial of a psycho-education intervention by midwives in reducing childbirth fear in pregnant women.
Birth. 2014;41(4):384-394. doi:
10.1111/birt.12136
PubMedGoogle ScholarCrossref 49.Dennis
CL, Hodnett
E, Kenton
L,
et al. Effect of peer support on prevention of postnatal depression among high risk women: multisite randomised controlled trial.
BMJ. 2009;338:a3064. doi:
10.1136/bmj.a3064
PubMedGoogle ScholarCrossref 55.Spielberger
C, Gorsuch
R, Lushene
R, Vagg
P, Jacobs
G. Manual for the State-Trait Anxiety Scale. Consulting Psychologists; 1983.
58.Le
H-N, Perry
DF, Stuart
EA. Randomized controlled trial of a preventive intervention for perinatal depression in high-risk Latinas.
J Consult Clin Psychol. 2011;79(2):135-141. doi:
10.1037/a0022492
PubMedGoogle ScholarCrossref 59.Milgrom
J, Holt
CJ, Gemmill
AW,
et al. Treating postnatal depressive symptoms in primary care: a randomised controlled trial of GP management, with and without adjunctive counselling.
BMC Psychiatry. 2011;11(1):95. doi:
10.1186/1471-244X-11-95
PubMedGoogle ScholarCrossref 67.Morrell
CJ, Slade
P, Warner
R,
et al. Clinical effectiveness of health visitor training in psychologically informed approaches for depression in postnatal women: pragmatic cluster randomised trial in primary care.
BMJ. 2009;338:a3045. doi:
10.1136/bmj.a3045
PubMedGoogle ScholarCrossref 84.Shorey
S, Chan
SW, Chong
YS, He
HG. A randomized controlled trial of the effectiveness of a postnatal psychoeducation programme on self-efficacy, social support and postnatal depression among primiparas.
J Adv Nurs. 2015;71(6):1260-1273. doi:
10.1111/jan.12590
PubMedGoogle ScholarCrossref 85.Shorey
S, Chee
CYI, Ng
ED, Lau
Y, Dennis
CL, Chan
YH. Evaluation of a technology-based peer-support intervention program for preventing postnatal depression (part 1): randomized controlled trial.
J Med Internet Res. 2019;21(8):e12410. doi:
10.2196/12410
PubMedGoogle Scholar 88.Dennis
CL, Grigoriadis
S, Zupancic
J, Kiss
A, Ravitz
P. Telephone-based nurse-delivered interpersonal psychotherapy for postpartum depression: nationwide randomised controlled trial.
Br J Psychiatry. 2020;216(4):189-196. doi:
10.1192/bjp.2019.275
PubMedGoogle ScholarCrossref 90.Singla
DR, Lemberg-Pelly
S, Lawson
A, Zahedi
N, Thomas-Jacques
T, Dennis
CL. Implementing psychological interventions through nonspecialist providers and telemedicine in high-income countries: qualitative study from a multistakeholder perspective.
JMIR Ment Health. 2020;7(8):e19271. doi:
10.2196/19271
PubMedGoogle Scholar 91.O’Connor
E, Rossom
RC, Henninger
M, Groom
HC, Burda
BU. Primary care screening for and treatment of depression in pregnant and postpartum women: evidence report and systematic review for the US Preventive Services Task Force.
JAMA. 2016;315(4):388-406. doi:
10.1001/jama.2015.18948
PubMedGoogle ScholarCrossref 92.Singla
DR, Ratjen
C, Krishna
RN, Fuhr
DC, Patel
V. Peer supervision for assuring the quality of non-specialist provider delivered psychological intervention: lessons from a trial for perinatal depression in Goa, India.
Behav Res Ther. 2020;130:103533. doi:
10.1016/j.brat.2019.103533
PubMedGoogle Scholar 94.World Health Organization. mhGAP Intervention Guide for Mental, Neurological and Substance Use Disorders in Non-Specialized Health Settings. World Health Organization; 2010.